Italy's new coronary pneumonia epidemic is very serious, but there has been no large-scale use of traditional Chinese medicine. Previously, Ealing Pharmaceuticals donated 100,000 boxes of Lianhua Qingdian capsules to Italy, which arrived with our first medical aid team. But Lianhua Qingdian capsule in Italy has not yet obtained the marketing license, specific so use this 10 boxes of Lianhua Qingdian capsule, need our medical team and the Italian side of the joint decision. However, according to Italy's "*** and the country newspaper" in April 2 report, Italy Tuscany Caleggi University Hospital under the scientific research institutions, plans to include Lianhua Qingdian capsule, including the effectiveness of herbal treatment of the new coronary arthritis test.
First, Italy's new coronary pneumonia epidemic is serious, but there has been no large-scale use of Chinese medicine. Currently, there have been as many as 115,242 confirmed cases of new coronary pneumonia in Italy, with 13,915 deaths, a mortality rate close to 12%, which is 2.5 times higher than the world's average mortality rate! After the outbreak of C.N.C. pneumonia in Italy, our country has successively sent three medical aid teams with a large amount of medical supplies. Among them, our first medical aid team medical team arrived in Rome, the capital of Italy, on the evening of March 12th.
Ealing Pharmaceuticals donated 100,000 boxes of Lianhua Qingdian capsules to Italy, which also arrived with the first medical aid team. However, the Italian side has not been large-scale use of Lianhua Qingdian capsule. March 31, Ealing Pharmaceuticals said in an interview with the surging news, the company did not receive the Italian order on Lianhua Qingdian capsule, Lianhua Qingdian capsule also did not obtain a marketing license in Italy. That is to say, Italy has not been large-scale use of Lianhua Qingdian capsule. As for the donation of 100,000 boxes of lotus clear distemper capsule specifics, Ealing Pharmaceuticals is not clear, saying that need to have our aid medical team and the Italian side **** with the decision.
Secondly, Chinese medicine has achieved good results in the treatment of neocoronaryngitis, which Italy has begun to evaluate. Since the outbreak of the New Crown Pneumonia epidemic, Lianhua Qingdian capsule has performed very eye-catching. In Thor Mountain Hospital, Vulcan Mountain Hospital and Square Cabin Hospital, Lianhua Qingdian capsule has been applied on a large scale. Academician Zhong Nanshan team also proved that Lianhua Qingdian capsule has the effect of inhibiting the activity of new coronavirus in vitro. At present, in Brazil, Indonesia, Canada, Mozambique, Romania, Thailand and other countries, Lianhua Qingdian capsule has obtained marketing license.
In addition, the Italian side in the knowledge of Lianhua Qingdian capsule and other traditional Chinese medicine on the treatment of new crown pneumonia, but also ready to start the effectiveness of the test. Italy's *** and the State newspaper reported on April 2, Carregi University General Hospital phytotherapy and integrative medicine research and development center head Ferenczoli said, has been with China's anti-epidemic medical expert group exchanges, learned of Chinese medicine for the treatment of new coronary pneumonia role. Therefore, Ferenzoli will cooperate with Italian antiviral experts to carry out a trial to verify whether TCM, including Lianhua Qingdian capsule, can play a therapeutic role in the treatment of neocoronavirus pneumonia.
Welcome to the discussion, do you think Italy will ultimately use Lianhua Qingdian capsule on a large scale to treat neocoronaryngitis?